JPMORGAN CHASE & CO - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 8 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$0
-100.0%
2,196
-61.9%
0.00%
Q3 2022$2,000
-99.6%
5,757
-99.0%
0.00%
Q2 2022$474,000
-97.2%
556,869
-81.8%
0.00%
-100.0%
Q1 2022$16,885,000
-44.8%
3,064,499
-3.1%
0.00%
-50.0%
Q4 2021$30,602,000
-30.2%
3,161,516
+28.9%
0.00%
-20.0%
Q3 2021$43,858,000
-23.9%
2,452,869
+3.9%
0.01%
-28.6%
Q2 2021$57,634,000
-3.9%
2,361,088
+4.4%
0.01%
-12.5%
Q1 2021$59,956,000
+205.3%
2,262,499
-12.5%
0.01%
+166.7%
Q4 2020$19,636,000
+68.5%
2,587,122
+12.1%
0.00%
+50.0%
Q3 2020$11,656,000
-5.3%
2,308,274
+12.2%
0.00%0.0%
Q2 2020$12,307,000
+135.7%
2,058,037
+75.4%
0.00%
+100.0%
Q1 2020$5,222,000
-30.6%
1,173,574
+48.2%
0.00%0.0%
Q4 2019$7,526,000
+29.1%
792,152
+6.7%
0.00%0.0%
Q3 2019$5,828,000
-42.5%
742,333
+9.6%
0.00%
-50.0%
Q2 2019$10,130,000
-7.4%
677,188
+12.0%
0.00%0.0%
Q1 2019$10,944,000
+105.3%
604,669
+82.5%
0.00%
+100.0%
Q4 2018$5,330,000
-29.0%
331,397
+5.9%
0.00%0.0%
Q3 2018$7,512,000312,9760.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders